SecBot SecBot
PRESS-RELEASE ·Filed Nov 2, 2026

BWAY

BrainsWay
NEUTRAL
Impact 3/10
Horizonmonths Processed14d 14h ago WireGlobeNewswire
Press release · Contract
Actionable Insight • Neutral

The collaboration is non-exclusive and lacks disclosed financial terms, so near-term revenue impact is uncertain. Monitor for any future revenue-sharing agreements or expansion of the Radial Health network that could drive adoption of BrainsWay's devices.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$11.09
T+0 close · Nov 2, 2026 · via day close
Latest settled
+4.96%
T+5 · $11.64 · next T+20 in 14d
Vs SPY
+4.88%
α at T+5
Latest observation
−9.59%
T+9 · FF3 residual α
  1. T+0 · Nov 2 $11.09entry
  2. T+1 · 14d ago +0.54%α +0.24% · $11.15
  3. T+5 · 8d ago +4.96%α +4.88% · $11.64
  4. T+10 · todayOpen
  5. T+20 · in 14d Pending
  6. T+60 · in 2mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

BrainsWay announced a strategic collaboration with Mindful Health Solutions (MHS), whose managed services organization was acquired by Radial Health, to expand patient access to BrainsWay's Deep TMS and accelerated SWIFT treatment protocol, and explore integration of Neurolief's ProlivRx at-home therapy. The collaboration includes joint physician education and research initiatives. BrainsWay also disclosed a recent $0.8M follow-on equity investment in the management services organization servicing the Heading Health clinic network.

Key Facts

  • BrainsWay entered a strategic collaboration with Mindful Health Solutions (MHS), now part of Radial Health, which operates 27 brain medicine clinics across 7 US states.
  • The collaboration aims to expand patient access to BrainsWay Deep TMS and accelerated SWIFT treatment protocol, and explore integration of Neurolief's ProlivRx at-home neuromodulation therapy.
  • BrainsWay made a follow-on equity investment of $0.8M in the management services organization servicing the Heading Health clinic network.
  • No financial terms of the collaboration were disclosed.

Financial Impact

No deal value disclosed; BrainsWay's $0.8M investment in Heading Health is small relative to its $479M market cap (0.17%).

revenuemarket access

Risk Factors

  • No financial terms disclosed; collaboration may not generate material revenue.
  • Forward-looking statements caution that investments in management services organizations may not produce profitable returns.
  • Competition from other TMS and neuromodulation providers could limit adoption.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3393040

Track record

24 reports on BWAY

Performance horizon

6 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +27.55% at T+60 after the Mar 4, 2026 report. 8 of 11 went positive at some point.

Filters
  1. Nov 10, 20266d ago 6-K Bullish 6/10 No price data
  2. Nov 10, 20266d ago 6-K Neutral 5/10 Entry $10.67 Now $9.39 −12.00% settles Dec 9
  3. Nov 2, 202614d ago 6-K Neutral 3/10 Entry $11.09 Now $9.39 −15.33% settles Dec 1
  4. Nov 2, 202614d ago Press Release Neutral 3/10 Viewing Entry $11.09 Now $9.39 −15.33% settles Dec 1
  5. Oct 26, 202621d ago 6-K Neutral 3/10 Entry $11.21 Now $9.39 −16.24% settles Nov 23
  6. Oct 21, 202626d ago 6-K Neutral 3/10 Entry $11.44 Now $9.39 −17.92% settles Nov 19
  7. Oct 19, 202628d ago 6-K Neutral 3/10 Entry $11.99 to $9.39 Now $9.39 −21.68% ▼ −21.68% −18.22% vs SPY
  8. Oct 19, 202628d ago Press Release Neutral 4/10 Entry $11.99 to $9.39 Now $9.39 −21.68% ▼ −21.68% −18.22% vs SPY
  9. Oct 13, 20264w ago 6-K Neutral 4/10 Entry $11.92 to $10.67 Now $9.39 −21.22% ▼ −10.49% −6.88% vs SPY
  10. Sep 8, 20269w ago 6-K Neutral 4/10 Entry $14.16 to $11.89 Now $9.39 −33.69% ▼ −16.03% −18.00% vs SPY
Showing 10 of 24

US Market Status

Market Closed · Opens Wed (11h 46m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026